How Physical Therapy Supports Safe, Sustainable Weight Loss At Lifeline Physical Therapy, we help individuals on GLP-1 therapy maintain strength, prevent muscle loss, and stay active
The goal is to maximize therapeutic benefitsimproved glycemic control and weight managementwhile minimizing side effects and supporting long-term adherence
Tirzepatide, which targets GLP-1 and GIP (but not glucagon), produces weight loss results of roughly 20-22% at its highest doses over 72 weeks
GLP-1 and GIP help lower appetite and increase insulin release, while glucagon can raise energy use and help the body burn fat
We have over 4 million happy customers worldwide and are present in over 40 countries across Europe
Endothelial progenitor cells as pathogenetic and diagnostic factors, and potential targets for GLP-1 in combination with metabolic syndrome and chronic obstructive pulmonary disease